Cargando…

Medicinal properties and conservation of Pelargonium sidoides DC.

ETHNOPHARMACOLOGICAL RELEVANCE: Pelargonium sidoides DC. (Geraniaceae), a popular medicinal plant used in traditional medicine in the treatment of gastrointestinal ailments has been transformed into a phytopharmaceutical (EPs(®) 7360) for treating respiratory tract infections. The increasing interna...

Descripción completa

Detalles Bibliográficos
Autores principales: Moyo, Mack, Van Staden, Johannes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ireland Ltd. 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127097/
https://www.ncbi.nlm.nih.gov/pubmed/24463034
http://dx.doi.org/10.1016/j.jep.2014.01.009
_version_ 1783516286858297344
author Moyo, Mack
Van Staden, Johannes
author_facet Moyo, Mack
Van Staden, Johannes
author_sort Moyo, Mack
collection PubMed
description ETHNOPHARMACOLOGICAL RELEVANCE: Pelargonium sidoides DC. (Geraniaceae), a popular medicinal plant used in traditional medicine in the treatment of gastrointestinal ailments has been transformed into a phytopharmaceutical (EPs(®) 7360) for treating respiratory tract infections. The increasing international demand for Pelargonium sidoides has led to localised overexploitation of its wild populations in southern Africa. The aim of the review is to provide a synthesis of the current state of scientific knowledge on the phytochemical, pharmacological and toxicological properties of Pelargonium sidoides as well as the potential role of plant biotechnology in its conservation. The review highlights knowledge gaps in these research areas. MATERIALS AND METHODS: A comprehensive literature search involving mainly electronic and library sources of information were used to collate and synthesise published data. RESULTS: Experimental results from in vitro studies indicate that bioactive phytochemical constituents of Pelargonium sidoides may not possess a direct antimicrobial effect, but instead act by interfering with microbial binding to host cell receptors, inhibition of key enzymes and the production of antimicrobial effector molecules such as nitric oxide and interferons (IFNs) by the host cells. Furthermore, clinical evaluations in randomised, double-blind, placebo-controlled trials have demonstrated the beneficial effect of Pelargonium sidoides in the treatment of respiratory tract infections with few side effects. However, there is lack of adequate information on the safety evaluation of the plant. On the other hand, the increasing demand for Pelargonium sidoides has led to localised illegal harvesting of wild plants. CONCLUSIONS: Pharmacological data reported in literature suggest that Pelargonium sidoides shows a beneficial effect in the treatment of respiratory tract infections. However, more studies are required to elucidate the mode of action of the active constituents exhibited in the treatment of respiratory tract infections and other health conditions caused by microbial attack. Furthermore, the pharmacological usefulness of Pelargonium sidoides must take cognisance of the broader context involving the need for conservation-friendly approaches in its utilisation. In this regard, plant biotechnology applications can play a meaningful role in a holistic conservation strategy.
format Online
Article
Text
id pubmed-7127097
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Elsevier Ireland Ltd.
record_format MEDLINE/PubMed
spelling pubmed-71270972020-04-08 Medicinal properties and conservation of Pelargonium sidoides DC. Moyo, Mack Van Staden, Johannes J Ethnopharmacol Article ETHNOPHARMACOLOGICAL RELEVANCE: Pelargonium sidoides DC. (Geraniaceae), a popular medicinal plant used in traditional medicine in the treatment of gastrointestinal ailments has been transformed into a phytopharmaceutical (EPs(®) 7360) for treating respiratory tract infections. The increasing international demand for Pelargonium sidoides has led to localised overexploitation of its wild populations in southern Africa. The aim of the review is to provide a synthesis of the current state of scientific knowledge on the phytochemical, pharmacological and toxicological properties of Pelargonium sidoides as well as the potential role of plant biotechnology in its conservation. The review highlights knowledge gaps in these research areas. MATERIALS AND METHODS: A comprehensive literature search involving mainly electronic and library sources of information were used to collate and synthesise published data. RESULTS: Experimental results from in vitro studies indicate that bioactive phytochemical constituents of Pelargonium sidoides may not possess a direct antimicrobial effect, but instead act by interfering with microbial binding to host cell receptors, inhibition of key enzymes and the production of antimicrobial effector molecules such as nitric oxide and interferons (IFNs) by the host cells. Furthermore, clinical evaluations in randomised, double-blind, placebo-controlled trials have demonstrated the beneficial effect of Pelargonium sidoides in the treatment of respiratory tract infections with few side effects. However, there is lack of adequate information on the safety evaluation of the plant. On the other hand, the increasing demand for Pelargonium sidoides has led to localised illegal harvesting of wild plants. CONCLUSIONS: Pharmacological data reported in literature suggest that Pelargonium sidoides shows a beneficial effect in the treatment of respiratory tract infections. However, more studies are required to elucidate the mode of action of the active constituents exhibited in the treatment of respiratory tract infections and other health conditions caused by microbial attack. Furthermore, the pharmacological usefulness of Pelargonium sidoides must take cognisance of the broader context involving the need for conservation-friendly approaches in its utilisation. In this regard, plant biotechnology applications can play a meaningful role in a holistic conservation strategy. Elsevier Ireland Ltd. 2014-03-14 2014-01-21 /pmc/articles/PMC7127097/ /pubmed/24463034 http://dx.doi.org/10.1016/j.jep.2014.01.009 Text en Copyright © 2014 Elsevier Ireland Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Moyo, Mack
Van Staden, Johannes
Medicinal properties and conservation of Pelargonium sidoides DC.
title Medicinal properties and conservation of Pelargonium sidoides DC.
title_full Medicinal properties and conservation of Pelargonium sidoides DC.
title_fullStr Medicinal properties and conservation of Pelargonium sidoides DC.
title_full_unstemmed Medicinal properties and conservation of Pelargonium sidoides DC.
title_short Medicinal properties and conservation of Pelargonium sidoides DC.
title_sort medicinal properties and conservation of pelargonium sidoides dc.
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127097/
https://www.ncbi.nlm.nih.gov/pubmed/24463034
http://dx.doi.org/10.1016/j.jep.2014.01.009
work_keys_str_mv AT moyomack medicinalpropertiesandconservationofpelargoniumsidoidesdc
AT vanstadenjohannes medicinalpropertiesandconservationofpelargoniumsidoidesdc